Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
A Study of Megestrol Acetate in HIV-Infected Children Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about A Study of Megestrol Acetate in HIV-Infected Children conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study of Megestrol Acetate in HIV-Infected Children Clinical research trials and A Study of Megestrol Acetate in HIV-Infected Children health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A Study of Megestrol Acetate in HIV-Infected Children. A Study of Megestrol Acetate in HIV-Infected Children Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a A Study of Megestrol Acetate in HIV-Infected Children clinical trial. Human subjects often get the best healthcare possible for their A Study of Megestrol Acetate in HIV-Infected Children condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Study of Megestrol Acetate in HIV-Infected Children

A Study of Megestrol Acetate in HIV-Infected Children



A Study of Megestrol Acetate in HIV-Infected Children

For Condition: HIV Infections
Status: Completed
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to see if megestrol acetate is safe and effective in treating HIV-infected children with failure to thrive (FTT).
Details: The study design is randomized, double-blind, placebo-controlled for 12 weeks with open-label drug offered after week 12.
Eligibility:
Study Type:  Interventional, Treatment, Double-Blind, Efficacy Study
Minimum Age/Maximum Age: 6 Months/18 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - Documented HIV infection. - Failure to thrive as defined by: - crossing 2 percentile lines on standard weight for age curves over time or less than 5% percentile weight for age and falling from the curve or loss of 10% of baseline body weight. - Resistant to oral nutritional supplementation (i.e., FTT despite a minimum 1-month trial of high-calorie oral supplements). - Free of significant acute illness (mild upper respiratory tract infections allowed). - Patients with chronic diarrhea allowed provided malabsorption and gastrointestinal infection ruled out. Exclusion Criteria Co-existing Condition: Patients with the following symptoms are excluded: - Gastrointestinal infection or malabsorption. - Significant acute illness. - Any identified, untreated cause for failure to thrive other than underlying HIV infection. - Medical contraindications to megestrol acetate. Patients with any of the following prior conditions or symptoms are excluded: Medical contraindications to megestrol acetate including a history of poorly-controlled hypertension, deep venous thrombosis, or heart failure. History of prior megestrol acetate therapy in the past six months.
Total Enrollment: 25

Location and Contact Information:

Univ of Puerto Rico / Med Science Campus
San Juan,  ,  00936
Puerto Rico
 


Additional Information:
Study ID Numbers:  266A;  Gamma 005
Study Start Date: 
Record last reviewed: July 1998
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002182

Other Hiv Infections Studies:
1. A Study of Zidovudine Plus Interleukin-2 in HIV-Infected Patients Who Have No Symptoms of Infection But Who Have Tender Lymph Nodes

2. A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents with HIV and their Mothers

3. The Effects of Zidovudine on the Blood of HIV-Infected Patients

4. A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

5. A Blood Test to Look at Cells of the Immune System in Healthy Children

Related Studies:

Other HIV Infections Clinical Trials
Other Clinical Trials
Other San Juan Clinical Trials

A Study of Megestrol Acetate in HIV-Infected Children
Modify your Search

  Other HIV Infections Clinical Trials
  Other Clinical Trials
  Other San Juan Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103